Pfizer, Myovant begin dosing in relugolix contraceptive study
Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet
Read More
Tag: contraceptive
UK launch for Bayer’s five-year contraceptive Kyleena
A new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has been launched in the UK.
Read More
Bayer bags EU nod for 5yr contraceptive
Bayer has been given a green light in the EU for its low-dose levonorgestrel-releasing intrauterine system as a means to prevent pregnancy.
Read More
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
